about
Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicositiesThree cases of stroke following peripheral venous interventions.Visual loss following sclerotherapy for varicose veinsThe VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.Foam sclerotherapy: cardiac and cerebral monitoring.Venous ulcers: new options in treatment: minimally invasive vein surgeryTwo-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence.Foam and liquid sclerotherapy for varicose veins.Polidocanol for endovenous microfoam sclerosant therapy.Complications and side-effects of foam sclerotherapy.Principles and technique of foam sclerotherapy and its specific use in the treatment of venous leg ulcers.Paradoxical embolism, stroke and sclerotherapy.Neurological complications of foam sclerotherapy: fears and reality.European guidelines for sclerotherapy in chronic venous disorders.Should foam made with physiologic gases be the standard in sclerotherapy?Comparison of microbubble presence in the right heart during mechanochemical and radiofrequency ablation for varicose veins.The evaluation of a novel technique to treat saphenous vein incompetence: preclinical animal study to examine safety and efficacy of a new vein occlusion device.The aetiology and influence of age and gender on the development of advanced chronic venous insufficiency in the population of patients of semi-urban county outpatient vascular clinic in Poland.Paradoxical cerebral air embolism causing large vessel occlusion treated with endovascular aspiration.Acoustic reflectors are visible in the right heart during radiofrequency ablation of varicose veins.Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux.Latest Innovations in the Treatment of Venous Disease.Cost-effectiveness analysis of five procedures for great saphenous vein reflux in a Norwegian healthcare setting or societal setting
P2860
Q27325488-C6045D98-764A-4799-B430-726986921291Q33605401-708D45AD-140F-4E45-B3B6-568ABEB02381Q33605442-D049BFAF-3A85-4532-B857-8C3348594E82Q33851102-022A10A0-058D-4562-9536-BB5230EFB4FAQ34707298-A198B9E3-5E48-4F9A-BC1C-F8236DC2ABD5Q34830380-44E6DDC2-6707-46C9-BE82-2D3987148137Q35015506-B782D5FA-D81D-41E1-B71E-3341521736ECQ35094183-D7D5695A-3BD6-4FE5-9B9B-D418580A09FFQ35162004-A5BC3187-8DDD-4F16-8089-D82D1650DC53Q37421100-C987A841-37E1-4DE7-8E37-6ED75A2A54C8Q37456712-352E66C1-0DD3-4619-8958-05362373CC12Q37642407-0DCEA9E3-DA18-4A23-A510-4A418E25A7B6Q37920505-FCEE0922-EAA8-4F72-B2A0-45A88993F732Q37926316-92979AAC-A5B9-4121-93E5-A821043C64B8Q37943695-BA604E53-AFEB-40D2-9312-D7379A26A461Q38096355-0CF50742-2403-4AD2-9C12-D9F3F6AA709BQ38267798-40549FE6-29AD-46CA-9031-8DF631455791Q38411692-5FE74664-9026-4BED-B3FB-BD47291E64D5Q39510107-48015E4D-9D1C-4560-B31B-B81AE08FB351Q39962468-7C4E1986-821C-4652-8535-060937FDA84BQ40391264-E619A772-3787-4391-A275-53E5676095BAQ47831183-81D235F5-7BE1-4A88-B686-C4755307A54EQ51134723-C84F6ED2-0C15-4EA2-8322-9C2BA55973A5Q52594205-C8CA85A8-2622-4E13-86B4-2B32E86BB16AQ58701249-9FE5FED5-F227-4BCB-82CA-3EA0786E4E57
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Major neurological events following foam sclerotherapy.
@ast
Major neurological events following foam sclerotherapy.
@en
type
label
Major neurological events following foam sclerotherapy.
@ast
Major neurological events following foam sclerotherapy.
@en
prefLabel
Major neurological events following foam sclerotherapy.
@ast
Major neurological events following foam sclerotherapy.
@en
P2093
P2860
P1433
P1476
Major neurological events following foam sclerotherapy.
@en
P2093
P2860
P304
P356
10.1258/PHLEB.2007.007073
P577
2008-01-01T00:00:00Z